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a b s t r a c t
In this study, for the first time, functionally active, recombinant, cysteine-rich plant proteins snakin-1
(SN1) and defensin (PTH1) were expressed and purified using a prokaryotic expression system. The over-
all level of antimicrobial activities of SN1 and PTH1 produced in Escherichia coli was commensurate with
that of the same proteins previously obtained from plant tissues. Both proteins exhibited strong antibac-
terial activity against the phytopathogenic bacterium Clavibacter michiganensis subsp. sepedonicus (50%
inhibitory concentration (IC50) 1.5–8 lM) and antifungal activity against the phytopathogenic fungi Col-
letotrichum coccoides and Botrytis cinerea (IC50 5–14 lM). Significantly weaker activity was observed
against Pseudomonas syringae pv. syringae and Pseudomonas syringae pv. tabaci. A pronounced synergistic
antimicrobial effect against P. syringae pv. syringae and an additive effect against P. syringae pv. tabaci
occurred with a combination of SN1 and PTH1. Aggregation of C. michiganensis subsp. sepedonicus bacte-
rial cells at all protein concentrations tested was observed with the combination of SN1 and PTH1 and
with SN1 alone. Our results demonstrate the use of a cost effective prokaryotic expression system for
generation and in vitro characterization of plant cysteine-rich proteins with potential antimicrobial activ-
ities against a wide range of phytopathogenic microorganisms in order to select the most effective agents
for future in vivo studies.
Published by Elsevier Inc.
Phytopathogenic bacteria and fungi cause significant losses in
important agricultural crops and are the primary cause of posthar-
vest diseases of fruits and vegetables. Postharvest losses are esti-
mated to range from 10% to 30% per year despite the use of
modern storage facilities and new crop conservation techniques
[1]. There are several ways to overcome this problem, including
application of chemicals [2], biological control [3], the induction
of natural plant defenses [4] and crop biotechnology [5]. However,
environmental safety problems, emergence of new virulent strains
of pathogens, resistance to the current chemical and biological de-
fenses, as well as practical difficulties, prevent full realization of
the aforementioned strategies under commercial conditions and
warrant development of new and more effective plant protection
techniques.
Recently the use of antimicrobial peptides, naturally produced
by a variety of microorganisms and plants, was proposed for bioen-
gineering and crop protection applications [6–9]. The decrease of
susceptibility to pathogen infection as a result of transgenic pro-
duction of antimicrobial agents in plants has been reported for
thionins [10,11], lipid transfer proteins (LTPs) [12], defensins
[13,14], snakins [15,16], and Leonurus japonicus antimicrobial pro-
tein (LJAMP1) [17], which have been isolated from such plants as:
Vigna unguiculata, Arabidopsis thaliana, Medicago sativa, Raphanus
sativus, Solanum tuberosum and Leonurus japonicus. The natural
production of such antimicrobial proteins in plants is thought to
be part of the constitutive or inducible defense mechanisms
against pathogens acquired by plants in the course of evolution
[18]. To characterize the antimicrobial properties of the proteins
listed above, a wide range of bacterial and fungal phytopathogens,
such as Erwinia chrysanthemi, Clavibacter michiganensis, Pseudomo-
nas cichorii, Ralstonia solanacearum, Alternaria alternata, Alternaria
brassicae, Aspergillus flavus, Aspergillus niger, Bipolaris maydis, Botry-
tis cinerea, Botrytis maydis, Cercospora personata, Colletotrichum glo-
eosporiodes, Colletotrichum lagenarium, Fusarium solani, Fusarium
oxysporum, Magnaporthe grisea, Pyricularia grisea, Rhizoctonia cere-
alis, Rhizoctonia solani, Trichoderma harzianum and Verticillium
dahliae, have been tested. Solanum lycopersicum, Solanum tubero-
sum, Nicotiana benthamiana and Nicotiana tabacum have been used
for genetic transformation, expression, and purification of recom-
binant antimicrobial proteins for subsequent microbiological
experiments in vitro, and for studies on the antimicrobial proper-
ties of these proteins in vivo [11,13,15]. It is important that the
selected proteins be tested on a wide variety of phytopathogenic
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microorganisms prior to performing plant transformation experi-
ments, which can be expensive, time-consuming and potentially
hindered by the limitations in the production of large quantities
of antimicrobial proteins, which typically require large amount of
plant tissue as a source of the biological material.
Prokaryotic protein expression is the most frequently used
method to produce recombinant proteins because it meets all the
above mentioned criteria, namely, is inexpensive, facilitates pro-
tein expression by its relative simplicity and allows achievement
of high density cultivation in a relatively short period of time. Fur-
thermore, there is currently a plethora of commercially available
kits designed for recombinant protein expression in bacteria. How-
ever, expression of recombinant proteins in Escherichia coli often
results in accumulation of the target proteins in the form of insol-
uble aggregates known as inclusion bodies (IBs). IBs usually consist
of almost pure, aggregated proteins which are typically misfolded
and thus biologically inactive [19]. In spite of the numerous known
reasons for the IB formation, to date there has been no universal
technique for efficient folding of the aggregation-prone recombi-
nant proteins [20,21]. Although there are few examples where for-
mation of IBs is highly desirable, such as their use for oral
vaccination as an alternate route for the delivery of recombinant
antigens for immunization [22], in most cases obtaining a recombi-
nant protein in the soluble form is absolutely crucial.
A number of techniques allowing for re-distribution of proteins
from IBs into the soluble cytoplasmic fraction have been described
in the literature. Those can be divided into the procedures involv-
ing direct refolding of proteins from IBs [23], using modified wash-
ing, solubilization, and folding conditions, and those based on
modified protein expression strategies to generate a recombinant
protein in its soluble form [24]. The latter involve protein expres-
sion under reduced temperatures (utilization of the cspA promoter)
[25], co-expression of the target proteins with chaperones (Cpn60
and Cpn10) which allows E. coli to grow at 4 C [26], the use of spe-
cial strains of E. coli, such as C41(DE3) and C43(DE3), to improving
expression of the soluble form of recombinant proteins [27], mod-
ification of superproducing strain cultivation conditions [28], and
the use of protein fusion technology to co-express molecular chap-
erones [29–31]. In spite of these modifications, the majority of
these approaches do not fully guarantee increased solubility of re-
combinant proteins. Therefore, individual approaches need to be
applied to solve the problems related to IB formation and solubli-
zation of each recombinant protein.
In the present study, we demonstrate the feasibility of generat-
ing functionally active antimicrobial plant proteins snakin-1
(SN1)1 [16] and defensin (PTH1) [32] in the pET-vector based
expression system. Attempts to express similar proteins in E. coli
have failed [14]. The aim of this study was to assess the antimicro-
bial potential of SN1 and PTH1 obtained from a prokaryotic expres-
sion system.
Materials and methods
Cloning of potato sn1 and pth1 genes
The coding regions of the potato snakin-1 (sn1) [16] and defen-
sin-1 (pth1) [32] genes were amplified from plasmid pP2C2S/SAP
(kindly provided by Dr. Y. Zhao) using PCR and primer pairs corre-
sponding to the N- and C-termini of the SN1 (SN1F/SN1R) and
PTH1 (PTH1F/PTH1R) proteins. The following N-terminal primers
were used—SN1F: 50-dCTTAGCCATGGCTGGTTCAAATTTTTGTG-30
and PTH1F: 50-dCTTAGCCATGGTTAGACATTGCGAGTCG-30 (Nco1
site is underlined), respectively. The following C-terminal primers
were used—SN1R: 50-TAAGAAGCTTTTATCAAGGGCATTTA-
GACTTGCCCTT-30 and PTH1R: 50-TAAGAAGCTTTTATCAGCATGGCT-
TAGTGCAAAAGCA-30 (HindIII site is underlined), respectively.
Carboxy-terminal 6His-tagged proteins containing a thrombin
cleavage recognition sequence (LeuValProArgGlySer) were de-
signed to facilitate purification using a Ni–NTA resin with subse-
quent removal of the 6His-tag from the expressed target
proteins by site-specific thrombin. The following C-terminal prim-
ers were used to produce these proteins: (SN1thrHisR:50-TAA-
GAAGCTTTTATCAGTGATGGTGATGGTGATGGCTGCCGCGCGGCACCA
GAGGGCATTTAGACTTGCCCTT-30 and PTH1thrHisR: 50-TAA-
GAAGCTTTTATCAGTGATGGTGATGGTGATGGCTGCCGCGCGGCACCAG
GCATGGCTTAGTGCAAAAGCA-30 (HindIII site is underlined, throm-
bin recognition sequence—italics). The PCR products were cloned
into the pCRII-TOPO Vector (Invitrogen, Carlsbad, CA), resulting
in recombinant plasmids pCRsn1, pCRpth1, pCRsn1thrHis, and
pCRpth1thrHis. These plasmids were subsequently digested with
NcoI and HindIII and the corresponding restriction fragments were
cloned into the plasmid vector pET26b+ (Novagen, Madison, WI) at
the NcoI/HindIII sites, giving rise to pET26b+sn1, pET26b+pth1,
pET26b+sn1thrHis, and pET26b+pth1thrHis, respectively. All con-
structs were verified by direct DNA sequencing.
Protein expression and characterization
Escherichia coli strain BL21 (DE3) (Stratagene, La Jolla, CA) was
used as a host for expression of the target genes. The transforma-
tion of pET26b+sn1, pET26b+pth1, pET26b+sn1thrHis, and
pET26b+pth1thrHis into E. coli was performed according to the
manufacturer’s instructions. The induction procedure for gene
expression was as follows: 2 ml of Luria–Bertani broth (LB) [20 g
of Bacto tryptone; 10 g of Bacto yeast extract and 20 g of NaCl
per liter of H2O] containing kanamycin (50 lg/ml) was inoculated
with a bacterial colony and incubated overnight at 225 rpm at
37 C. Five hundred microliters of overnight culture were trans-
ferred into a flask containing 50 ml of LB medium with the same
antibiotic (50 lg/ml), and agitated at 225 rpm at 37 C until the
culture density reached an OD600 of 0.7–0.8. IPTG was added to fi-
nal concentration 1.5 mM with subsequent incubation at 225 rpm
at 37 C for 7 h. After incubation, the bacterial cells were harvested
by centrifugation in 50 ml Falcon tubes at 4000 rpm for 20 min at
4 C and frozen at 80 C. A non-induced culture was used as a
negative control.
Protein extraction
The BugBuster Master Mix Protein Extraction Reagent (Nova-
gen) was used to extract the expressed proteins from bacterial
lysates. The extraction was carried out according to the manufac-
turer’s instructions.
IB purification, solubilization and refolding
IBs were purified using BugBuster Master Mix Protein Extrac-
tion Reagent (Novagen) according to a standard procedure (Nova-
gen, User protocol TB245 Rev. E 0304, P.8). Solubilization of the
subsequent IBs was carried out using the Protein Refolding Kit
(Novagen). Specifically, the IBs solubilization buffer was supple-
mented with 1 mM DTT for correct folding of disulfide bonds and
with 2% N-lauroylsarcosine to reduce hydrophobic aggregation.
The solubilized proteins were dialyzed against 20 mM Tris–HCl
pH 8.0 four times at 4 C. The first and second dialysis buffers were
supplemented with 0.1 mM DTT.
Aliquots of the SN1 and PTH1 proteins were subjected to dena-
turing electrophoresis in a gradient Novex Tris–Glycine Gel
(10–20%; Invitrogen, Carlsbad, CA) according to the manufacturer’s
1 Abbreviations used: SN1, snakin-1; LTPs, lipid transfer proteins; LJAMP1, leonurus
japonicus antimicrobial protein; IBs, inclusion bodies; LB, Luria–Bertani broth; PDA,
potato dextrose agar.
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instructions and visualized by staining with SimplyBlue Safe Stain
(Invitrogen).
The protein concentration was measured with the Quick StartTM
Bradford Dye Reagent (Bio-Rad, Hercules, CA) using a standard
method [33] and a microplate reader 680 (Bio-Rad). All the ex-
tracted proteins were stored at 20 C in 50% glycerol.
Protein purification with nickel–nitrilotriacetic acid (Ni–NTA) metal-
affinity chromatography matrices
The Ni–NTA Spin Kit (QIAGEN, Valencia, CA) was used for puri-
fication of the target proteins. The purification was carried out
according to the manufacturer’s instructions.
Western blot analysis
Twelve microliters of the soluble SN1thrHis (1.9 mg/ml) and
PTH1thrHis (2.3 mg/ml) were loaded on a gradient Novex Tris–
Glycine Gel (10–20%) and transferred to a nitrocellulose membrane
(Invitrogen). The membrane was probed with a 1:3000 dilution of
monoclonal anti-polyhistidine clone HIS-1 (mouse IgG2a isotype)
antibodies (Sigma, Saint Louis, MO) followed by a 1:5000 dilution
of goat anti-mouse phosphatase-labeled Antibodies (Kirkegaard &
Perry Laboratories, Inc., Gaithersburg, MD). The membrane was
developed by utilizing the BCIP/NBT Phosphatase Substrate System
(Kirkegaard & Perry Laboratories, Inc.).
Microorganisms
The following phytopathogenic microorganisms were used:
Clavibacter michiganensis subsp. sepedonicus AS1 (I.-M. Lee, Molec-
ular Plant Pathology Laboratory, United States Department of Agri-
culture, Beltsville, MD, US); Pseudomonas syringae pv. syringae 61,
Pseudomonas syringae pv. tabaci 11528 Race 0 (C.J. Baker, Molecular
Plant Pathology Laboratory, United States Department of Agricul-
ture, Beltsville, MD, US); Collectotrichum coccoides and B. cinerea
(R. Jones, Genetic Improvement of Fruit and Vegetables Laboratory,
United States Department of Agriculture, Beltsville, MD, US).
Clavibacter michiganensis subs. sepedonicus, a gram-positive bac-
terium, was grown on nutrient-broth yeast extract agar (NBY)
[8.0 g of nutrient-broth (Difco, Detroit), 2.0 g of yeast extract,
2.0 g of K2HPO4, 0.5 g of KH2PO4, 2.5 g of glucose and 15.0 g of Bac-
to agar per 1 L of H2O; after auto claving, 1.0 ml of a sterile solution
of 1 M MgSO4 was added]. After inoculation of solid medium with
the bacterium, the plates were incubated for five days at 28 C. The
colonies from the plate were transferred into a culture tube con-
taining NBY broth and grown at 28 C with vigorous shaking
(250 rpm) for 192 h.
Pseudomonas syringae pv. syringae and P. syringae pv. tabaci,
gram-negative bacteria, were grown in KB medium previously de-
scribed by King et al. [34] (KB) [20.0 g of Proteose peptone #3 (Dif-
co, Detroit, MI), 1.5 g K2HPO4, 15.0 ml glycerol, 15.0 g Bacto agar
per liter H2O; after autoclaving, 6.0 ml of a sterile solution of 1 M
MgSO4 was added]. The culture plates were incubated for two days
at 28 C. The colonies from the plate were transferred into a tube
containing KB broth and grown at 28 C with shaking (250 rpm)
overnight.
C. coccoides and B. cinerea were routinely cultured on potato
dextrose agar (PDA) (Difco) plates for approximately 14 days at
room temperature. For antifungal assays, the spores were collected
and suspended in PDB (Sigma–Aldrich, Inc., St. Louis, MO). Spore
concentrations were determined using a hemacytometer and a
light microscope.
Antibacterial assays
The antibacterial activities of the purified proteins were deter-
mined by counting bacterial CFU (colony forming units). Inhibition
assays were performed in sterile 10 ml Falcon tubes (BD, Franklin
Lakes, NJ). Each protein concentration was tested with three repli-
cations. Bacterial suspensions were combined with a fixed volume
of the proteins, adjusted by the appropriate medium to a particular
concentration. The bacterial concentration at the beginning of
experiment was 1  104 CFU per ml for C. michiganensis subsp.
sepedonicus, 4  105 CFU per ml for P. syringae pv. syringae and
8  104 CFU per ml for P. syringae pv. tabaci. The final protein con-
centrations used in all antibacterial assays were 0, 1, 2, 7 and
14 lM. The total volume of the protein–bacterial mix was 1 ml.
Tubes were incubated at 28 C with continuous shaking at
250 rpm for 192 h and 48 h for C. michiganensis subsp. sepedonicus
and pseudomonads, respectively. Following incubation, 100 ll ali-
quots of protein-treated bacterial cultures were serially diluted in
sterile water (from 102- to 106-fold) and 25 ll of diluted bacte-
rial suspensions were spread onto the appropriate solid medium.
The plates were incubated at 28 C and examined for bacterial
growth by counting CFU at 5 and 2 days for C. michiganensis subsp.
sepedonicus and pseudomonads, respectively. This scheme was ap-
plied for both SN1 and PTH1 proteins.
Antifungal assays
The antifungal activities of the purified proteins were deter-
mined by counting germinating and non-germinating protein-trea-
ted fungal spores. The fungal spores were prepared in PDB. For the
inhibition assays, spore suspensions of 1  105 spores/ml of C. coc-
coides and B. cinerea were mixed in 1.5 ml test tubes with SN1 and
PTH1 proteins adjusted by PDB so that final concentrations were 0,
1, 2, 7 and 14 lM. Each antifungal assay was performed in three
replicates. The total volume of protein–fungus combination was
50 ll. Twenty-five microliters of the mix of each variant was ap-
plied on the surface of a hemacytometer, which was placed into
a humid chamber (Petri dish with wet filter paper). The inhibitory
activity on fungal spore germination was determined after 12 h of
incubation at 28 C for C. coccoides and 14 h of incubation at room
temperature for B. cinerea by visualization using a light micro-
scope. This scheme was applied for both proteins.
Results
Expression of SN1 and PTH1 proteins in E. coli
To obtain purified SN1 and PTH1 recombinant proteins and to
determine their antimicrobial activity, we constructed expression
cassettes pET26b+sn1 and pET26b+pth1, which were transformed
into E. coli BL21 (DE3) cells for protein expression. The expression
vector pET26b+ was chosen because it provides the N-terminal
pelB signal sequence to the expressed proteins, which should facil-
itate their localization to the periplasm and reduce or eliminate IB
formation. However, analysis of the total and soluble fractions of
the expressed SN1 and PTH1 proteins by gel electrophoresis dem-
onstrated that SN1 and PTH1 were localized exclusively in the
insoluble fraction (IBs) (Fig. 1).
Our attempts to express the proteins at a lower temperature
(25 C) in order to avoid IB formation or extraction of the proteins
from IBs using sonication or solubilization by 8 M urea failed as
well. The IBs containing SN1 and PTH1 were purified and solubi-
lized as described (see Materials and methods). When the solubi-
lized IBs were analyzed by gel electrophoresis, the sizes of the
proteins were consistent with the predicted molecular masses of
SN1 and PTH1 (Fig. 2).
We also engineered SN1 and PTH1 with a carboxy terminal, 6
histidine fusion containing an embedded thrombin cleavage site in
order to facilitate purification, creating SN1thrHis and PTH1thrHis,
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respectively. Attempts to purify the resulting proteins after IB sol-
ubilization and protein refolding failed as well. To verify the pres-
ence of the polyhistidine tags in SN1 and PTH1 these proteins were
subjected to Western blot analysis using a monoclonal anti-poly-
histidine antibody. The results confirmed the presence of polyhis-
tidine on both expressed proteins (Fig. 3). Thus, we believe that our
inability to affinity-purify the target proteins using the Ni–NTA
spin column could be accounted for by some conformational alter-
ations in those proteins following their refolding, subsequently
hiding the polyhistidine tags inside the protein structure and ren-
dering them inaccessible for binding to the resin. Based on this
observation the SN1 and PTH1 protein variants without polyhisti-
dine were used for all the microbiological assays.
Attempts to analyze the structural properties of our proteins by
analytical reverse phased HPLC and mass spectrometry failed (data
not shown). For example, there were extremely heterogeneous
peaks in one sample, with the most abundant peak appearing at
25 kDa. As our samples were prepared for optimum activity in
the antimicrobial assays (purification from inclusion bodies and
refolding) and not for physical evaluation, it may be that the pro-
teins remained aggregated. Alternatively, the cysteine-rich nature
of the proteins may interfere with the analyses. In addition, the
protein concentrations of the solubilized peptides were deter-
mined using the Bradford reagent, and visual inspection of the gra-
dient Novex Tris–Glycine Gel (10–20%) (Fig. 2) revealed that the
majority of the proteins in the sample lanes are the recombinant
peptides. Therefore, protein concentrations calculated using the
Bradford reagents were used to determine the molarity of peptides
for the antimicrobial assays, but may not reflect the actual amount
of functional protein in the samples.
Analysis of the antimicrobial activity of SN1 and PTH1
To assess the antimicrobial activities of the purified SN1 and
PTH1 proteins, we performed a number of antibacterial and anti-
fungal growth inhibition assays as described in Materials and
methods. The results demonstrated that C. michiganensis subsp.
sepedonicus, P. syringae pv. syringae, P. syringae pv. tabaci, C. cocco-
ides and B. cinerea were all affected by SN1 and PTH1, although to
differing degrees (Fig. 4). Among the bacteria we tested, C. michi-
ganensis subsp. sepedonicus was the most susceptible to both pro-
teins and growth was completely inhibited by 14 lM of SN1 and
7 lM of PTH1. P. syringae pv. syringae and P. syringae pv. tabaci
showed a low level of sensitivity to both proteins. There was no
significant growth inhibition of P. syringae pv. syringae at the high-
est protein concentrations used in our experiments. In contrast,
14 lM of SN1 and PTH1 led to about 20% and 50% inhibition of
the P. syringae pv. tabaci cells, respectively.
For the fungal pathogens, 14 lM of SN1 led to a complete inhi-
bition of C. coccoides spore germination, while only about 90% inhi-
bition of spore germination was achieved by the same
concentration of PTH1 (Fig. 4) B. cinerea showed different re-
sponses to treatments with SN1 and PTH1. Spore germination
was completely inhibited with 14 lM of SN1 whereas the same
concentration of PTH1 led only to 50% inhibition (Fig. 4). Thus C.
Fig. 1. Denaturing 10–20% polyacrylamide gel electrophoretic analysis of soluble
(S) and total (T) fractions of SN1 and PTH1 expressed in E. coli. Sample lanes contain
either 2 lg (S) or 4 lg (T) protein for both SN1 and PTH1. kDa = Precision Plus
Protein Kaleidoscope standards (Bio-Rad). The gel was stained with SimplyBlue Safe
Stain (Invitrogen).
Fig. 2. Electrophoretic analysis of SN1 and PTH1 proteins after IB purification,
solubilization, and protein refolding, as in Fig. 1. kDa = Precision Plus Protein
Kaleidoscope standards (Bio-Rad). Lane 1 – SN1, 5 lg; Lane 2 – PTH1, 8 lg. The gel
was stained with SimplyBlue Safe Stain (Invitrogen).
Fig. 3. Western blot analysis of SN1thrHis and PTH1thrHis after IB solubilization
and protein refolding. The membrane was incubated with a monoclonal anti-
polyhistidine clone HIS-1 (mouse IgG2a isotype) antibody followed by goat anti-
mouse IgG as described in Material and Methods. kDa = BenchMarkTM His-tagged
protein standards (Invitrogen). Lane 1 – SN1thrHis, 23 lg; Lane 2 – PTH1thrHis,
28 lg.
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coccoides appears to be the most sensitive to action of the proteins
between the fungi tested.
A synergistic effect of SN1 and PTH1 used in combination was
observed against bacteria P. syringae pv. syringae and an additive
effect was observed against P. syringae pv. tabaci (Fig. 5).
Aggregation of the bacterial cells was observed only for bacte-
rial culture C. michiganensis subsp. sepedonicus upon treatment
with SN1 alone as well as the combination of SN1 and PTH1 at
all the concentrations tested (data not shown). In contrast, no
aggregation was observed for P. syringae pv. syringae or P. syringae
pv. tabaci in our experiments.
Discussion
In this study, we demonstrate, for the first time, the production
of functionally active plant SN1 and PTH1 proteins, suitable for
antimicrobial in vitro assays, using a prokaryotic expression sys-
tem. SN1 and PTH1, naturally occurring in the potato tuber, are
highly basic, cysteine-rich proteins that form six and four struc-
ture-stabilizing disulfide bridges, respectively [16,32,35]. The
expression of SN1 and PTH1 in E. coli from the pET plasmid vector
resulted in formation of IBs. Analysis of purified and solubilized IBs
by gel electrophoresis showed that the target proteins were pres-
ent in bacterial cells predominantly in the form of insoluble aggre-
gates. It is well known that, in most cases, adjustment of IB
washing conditions allows isolation of IBs containing more then
90% pure recombinant protein [36]. We took advantage of this ap-
proach in our study and it allowed us to successfully obtain puri-
fied preparations of SN1 and PTH1 that were used in our
microbiological assays.
The presence of antibacterial and antifungal activities was dem-
onstrated in our in vitro experiments for both SN1 and for PTH1
proteins expressed in E. coli. The overall level of those activities
was similar to those of proteins obtained from the plant tissues
[15,16,32]. Remarkably, the recombinant PTH1 showed a several-
fold higher inhibitory activity against C. michiganensis subsp. sepe-
donicus as compared to that previously reported for PTH1 obtained
from the plant tissues [16,32]. In previous reports, it has also been
shown that the spectrum of the SN1 activity is distinct from that of
PTH1. In particular, SN1 is active against both bacterial and fungal
species, whereas PTH1, while showing a considerable antifungal
activity, possesses little antibacterial activity [14,16,37]. However,
the clearly defined difference between the spectra of antimicrobial
activities of both proteins was not observed in our experiments.
We found that both SN1 and PTH1 possess significant antibacterial
activities against C. michiganensis subsp. Sepedonicus. However,
while SN1 was active against both C. coccoides and B. cinerea fungal
pathogens, PTH1 had more inhibitory activity against C. coccoides.
In our work we also observed a synergistic effect of SN1 and
PTH1 used in combination against cultures of P. syringae pv. syrin-
gae and an additive effect against cultures of P. syringae pv. tabaci,
which is fully consistent with the synergistic and additive antimi-
crobial effects against phytopathogens previously reported for
both SN1 and PTH1 [16].
SN1 resulted in aggregation of the gram-positive bacteria
C. michiganensis subsp. sepedonicus at all the concentrations tested;
however, there was no correlation with the antibacterial activity of
this protein in vitro. Our data confirm those described in previous
reports with regard to snakins: snakin-1 and snakin-2 [15,16]. It
is believed that the aggregation effect plays a role in the control
of pathogens in vivo, providing a protective barrier against spread-
ing of infectious agents through the living organism [15,38]. How-
ever, the exact mechanism of action of snakins remains unknown.
In conclusion, the recombinant plant SN1 and PTH1 proteins
overexpressed in and purified from E. coli possessed distinct anti-
bacterial and antifungal activities commensurate with activities
of the same proteins obtained from plant tissues. The observation
that the antimicrobial peptides were not toxic to the E. coli host
used to produce the proteins may be explained by fact that the
pET26b+ vector contains a tightly controlled T7lacpromoter in
BL21 (DE3) cells, where basal level transcription is low until
induced by IPTG [39], and that the bacteria sequester the toxic pro-
Fig. 5. Synergistic antimicrobial effect of a combination of SN1 and PTH1 against
phytopathogenic microorganisms. The left bar of each treatment is P. syringae pv.
syringae and the right bar is P. syringae pv. tabaci. Each result is the mean of three
replications.% inhibition represents CFU. Values are expressed as ± 5%.
Fig. 4. The antimicrobial effect of SN1 (A) and PTH1 (B) on various phytopathogenic
microorganisms.% inhibition on the Y-axis refers to CFU in bacteria (C. michigen-
ensis, P. syringae pv. syringae, P. syringae pv. tabaci) and spore germination in fungi
(C. coccoides, B. cinerea). Each result is a mean of three replications. Values are
expressed as means ± 5%. The legend on the graph refers to samples in both
(A and B).
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teins into IBs where they are not functional [19]. Although we were
unable to perform physical evaluations of the proteins by analyti-
cal reverse phased HPLC and mass spectrometry, the proteins were
highly active biologically.
It is important to note that production of recombinant proteins
in plant tissues is an expensive and time-consuming procedure,
typically yielding suboptimal quantities of transgenic proteins that
may not be sufficient for biological assays. In this regard, our study
demonstrates the use of a less costly and technically more advan-
tageous prokaryotic expression system for generation of cysteine-
rich antimicrobial proteins that are suitable for in vitro biological
characterization. Proteins with the best antimicrobial characteris-
tics demonstrated in initial in vitro assays on a broad range of
microorganisms can be selected for further evaluation in vivo.
Acknowledgments
We thank Dr. C.J. Baker and Dr. I.-M. Lee (Molecular Plant
Pathology Laboratory, United States Department of Agriculture,
Beltsville, MD, US) for the gifts of the phytopathogenic bacterial
strains and technical support. We thank Dr. W. Wu (University of
Maryland School of Medicine, Baltimore, MD) for his attempts to
perform the analytical reversed phase HPLC and mass spectrome-
try analysis of the purified proteins. We acknowledge Dr. R. Jones
(Genetic Improvement of Fruit and Vegetables Laboratory, United
States Department of Agriculture, Beltsville, MD, US) for the gift
of the phytopathogenic fungal strains. The respective pathogens
remained under control of the donor laboratories. We also thank
Dr. Y. Zhao (Molecular Plant Pathology Laboratory, United States
Department of Agriculture, Beltsville, MD, US) for the gift of plas-
mid pP2C2S/SAP and helpful discussions, and Dr. A. Borovjagin
(Institute of Oral Health Research Department of Periodontics
UAB School of Dentistry, University of Alabama at Birmingham,
AL, US) who assisted with the preparation of this manuscript.
References
[1] J.M. Harvey, Reduction of losses in fresh fruits and vegetables, Ann. Rev.
Phytopath. 16 (1978) 321–341.
[2] G.N. Agrios, Plant Pathology, fourth ed., Academic Press, San Diego, CA, 1997.
[3] L.S. Thomashow, D.M. Weller, Current concepts in the use of introduced
bacteria for biological disease control: mechanism and antifungal metabolites,
in: G. Stacey, N.T. Keen (Eds.), Plant-Microbe Interactions, vol. 1, Chapman and
Hall, New York, 1996, pp. 187–235.
[4] G.D. Lyon, T. Reglinski, A.C. Newton, Novel disease control compounds: the
potential to ‘immunize’ plants against infection, Plant Pathol. 44 (1995) 407–
427.
[5] C.J. Lamb, J.A. Ryals, E.R. Ward, R.A. Dixon, Emerging strategies for enhancing
crop resistance to microbial pathogens, Biotechnology 10 (1992) 1436–1445.
[6] W.F. Broekaert, B.P. Cammue, M.F. De Bolle, K. Thevissen, G.W. De Samblanx,
R.W. Osborn, Antimicrobial peptides from plants, Crit. Rev. Plant Sci. 16 (1997)
297–323.
[7] M.J. Carmona, A. Molina, J.A. Fernandez, J.J. Lopez-Fando, F. Garcia-Olmedo,
Expression of the alpha-thionin gene from barley in tobacco confers enhanced
resistance to bacterial pathogens, Plant J. 3 (1993) 457–462.
[8] Y. Huang, R.O. Nordeen, M. Di, L.D. Owens, J.H. McBeath, Expression of an
engineered cecropin gene cassette in transgenic tobacco plants confers
resistance to Pseudomonas syringae pv. tabaci, Phytopathology 87 (1997)
494–499.
[9] A.G. Rao, Antimicrobial peptides, Mol. Plant Microbe Interact. 8 (1995) 6–13.
[10] Y.L. Chan, V. Prasad, C. Sanjaya, K.H. Chen, P.C. Liu, M.T. Chan, C.P. Cheng,
Transgenic tomato plants expressing an Arabidopsis thionin (Thi2.1) driven by
fruit-inactive promoter battle against phytopathogenic attack, Planta 221
(2005) 386–393.
[11] O.L. Franco, A.M. Murad, J.R. Leite, P.A. Mendes, M.V. Prates, C. Bloch,
Identification of cowpea gamma-thionin with bactericidal activity, FEBS J.
273 (2006) 3489–3497.
[12] A. Molina, F. Garcia-Olmedo, Enhanced tolerance to bacterial pathogens
caused by the transgenic expression of barley lipid transfer protein LTP2, Plant
J. 12 (1997) 669–675.
[13] A.G. Gao, S.M. Hakimi, C.A. Mittanck, Y. Wu, B.M. Woerner, D.M. Stark, D.M.
Shah, J. Liang, C.M.T. Rommens, Fungal pathogen protection in potato by
expression of plant defensin peptide, Nat. Biotechnol. 18 (2000) 1307–1310.
[14] H. Saitoh, A. Kiba, M. Nishihara, S. Yamamura, K. Suzuki, R. Terauchi,
Production of antimicrobial defensin in Nicotiana benthamiana with a Potato
Virus X vector, Mol. Plant Microbe Interact. 14 (2001) 111–115.
[15] M. Berrocal-Lobo, A. Segura, M. Moreno, G. Lopez, F. Garcia-Olmedo, A. Molina,
Snakin-2, an antimicrobial peptide from potato whose gene is locally induced
by wounding and responds to pathogen infection, Plant Physiol. 128 (2002)
951–961.
[16] A. Segura, M. Moreno, F. Madueno, A. Molina, F. Garcia-Olmedo, Snakin-1, a
peptide from potato that is active against plant pathogens, Mol. Plant Microbe
Interact. 12 (1999) 16–23.
[17] X. Yang, Y. Xiao, X. Wang, Y. Pei, Expression of a novel small antimicrobial
protein from the seeds of Motherwort (Leonurus japonicus) confers disease
resistance in tobacco, Appl. Environ. Microbiol. 73 (2007) 939–946.
[18] P. Veronese, M.T. Ruiz, M.A. Coca, A. Hernandez-Lopez, H. Lee, J.I. Ibeas, B.
Damsz, J.M. Pardo, P.M. Hasegawa, R.A. Bressan, M.L. Narasimhan, In defense
against pathogens. Both plant sentinels and foot soldiers need to know the
enemy, Plant Physiol. 131 (2003) 1580–1590.
[19] A. Villaverde, M.M. Carrio, Protein aggregation in recombinant bacteria:
biological role of inclusion bodies, Biotechnol. Lett. 25 (2003) 1385–1395.
[20] R.S. Rajan, M.E. Illing, N.F. Bence, R.R. Kopito, Specificity in intracellular protein
aggregation and inclusion body formation, Proc. Natl. Acad. Sci. USA 98 (2001)
13060–13065.
[21] R. Vincentelli, S. Canaan, V. Campanacci, C. Valencia, D. Maurin, F. Frassinetti, L.
Scappucini-Calvo, Y. Bourne, C. Cambillau, C. Bignon, High-throughput
automated refolding screening of inclusion bodies, Protein Sci. 13 (2004)
2782–2792.
[22] M. Ke˛sik, V. Sa˛czyn´ska, B. Szewczyk, A. Płucienniczak, Inclusion bodies from
recombinant bacteria as a novel system for delivery of vaccine antigen by the
oral route, Immunol. Lett. 91 (2004) 197–204.
[23] A. Middelberg, Preparative protein refolding, Trends Biotechnol. 20 (2002)
437.
[24] H.P. Sørensen, K.K. Mortensen, Soluble expression of recombinant proteins in
the cytoplasm of Escherichia coli, J. Biotechnol. 115 (2005) 113–128.
[25] M. Mujacic, K.W. Cooper, F. Baneyx, Cold-inducible cloning vectors for low-
temperature protein expression in Escherichia coli: application to the
production of a toxic and proteolytically sensitive fusion protein, Gene 238
(1999) 325–332.
[26] M. Ferrer, T.N. Chernikova, K.N. Timmis, P.N. Golyshin, Expression of a
temperature-sensitive esterase in a novel chaperone-based Escherichia coli
strain, Appl. Environ. Microbiol. 70 (2004) 4499–4504.
[27] L. Dumon-Seignovert, G. Cariot, L. Vuillard, The toxicity of recombinant
proteins in Escherichia coli: a comparison of overexpression in BL21(DE3),
C41(DE3), and C43(DE3), Protein Expr. Purif. 37 (2004) 203–206.
[28] G. Lewis, I.W. Taylor, A.W. Nienow, C.J. Hewitt, The application of multi-
parameter flow cytometry to the study of recombinant Escherichia coli batch
fermentation processes, J. Ind. Microbiol. Biotechnol. 31 (2004) 311–322.
[29] F.U. Hartl, M. Hayer-Hartl, Molecular chaperones in the cytosol: from nascent
chain to folded protein, Science 295 (2002) 1852–1858.
[30] R.B. Kapust, D.S. Waugh, Escherichia coli maltose-binding protein is
uncommonly effective at promoting the solubility of polypeptides to which
it is fused, Protein Sci. 8 (1999) 1668–1674.
[31] H.P. Sørensen, K.K. Mortensen, Advanced genetic strategies for recombinant
protein expression in Escherichia coli, Microb. Cell Fact. 4 (2005) 1–12.
[32] M. Moreno, A. Segura, F. Garcia-Olmeda, Pseudothionin-St1, a potato peptide
active against potato pathogens, Eur. J. Biochem. 223 (1994) 135–139.
[33] M.M. Bradford, A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding, Anal. Biochem. 72 (1976) 248–254.
[34] E.O. King, M.K. Ward, D.E. Raney, Two simple media for demonstration of
pycocyanin and fluorescin, J. Lab. Clin. Med. 44 (1954) 301–307.
[35] B.P.H.J. Thomma, B.P.A. Cammue, K. Thevissen, Plant defensins, Planta 216
(2002) 193–202.
[36] J. Sambrook and D. W. Russell (2001) Molecular cloning: a laboratory manual,
third ed. http://www.MolecularCloning.com, 3, 15–49.
[37] W.F. Broekaert, F.R. Terras, B.P. Cammue, R.W. Osborn, Plant defensins: novel
antimicrobial peptides as components of the host defense system, Plant
Physiol. 108 (1995) 1353–1358.
[38] J. Pérez-Vilar, R.L. Hill, The structure and assembly of secreted mucins, J. Biol.
Chem. 274 (1999) 31751–31754.
[39] J.W. Dubendorff, F.W. Studier, Controlling basal expression in an inducible T7
expression system by blocking the target T7 promoter with lac repressor,
J. Mol. Biol. 219 (1991) 45–59.
N. Kovalskaya, R.W. Hammond / Protein Expression and Purification 63 (2009) 12–17 17
